Cargando…

CSF Biomarkers in the Early Diagnosis of Mild Cognitive Impairment and Alzheimer’s Disease

Alzheimer’s disease (AD) is a rapidly growing disease that affects millions of people worldwide, therefore there is an urgent need for its early diagnosis and treatment. A huge amount of research studies are performed on possible accurate and reliable diagnostic biomarkers of AD. Due to its direct c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Papaliagkas, Vasileios, Kalinderi, Kallirhoe, Vareltzis, Patroklos, Moraitou, Despoina, Papamitsou, Theodora, Chatzidimitriou, Maria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10218948/ https://www.ncbi.nlm.nih.gov/pubmed/37240322 http://dx.doi.org/10.3390/ijms24108976

Ejemplares similares

Alzheimer’s Disease as Type 3 Diabetes: Common Pathophysiological Mechanisms between Alzheimer’s Disease and Type 2 Diabetes
por: Michailidis, Michalis, et al.
Publicado: (2022)

Antidiabetic Drugs in the Treatment of Alzheimer’s Disease
por: Michailidis, Michalis, et al.
Publicado: (2022)

Antioxidant Potential of Spray- and Freeze-Dried Extract from Oregano Processing Wastes, Using an Optimized Ultrasound-Assisted Method
por: Vareltzis, Patroklos, et al.
Publicado: (2023)

Trajectories of Cognitive Impairment in Adults Bearing Vascular Risk Factors, with or without Diagnosis of Mild Cognitive Impairment: Findings from a Longitudinal Study Assessing Executive Functions, Memory, and Social Cognition
por: Tsentidou, Glykeria, et al.
Publicado: (2022)

Correlates of Functional Impairment in Patients with the Behavioral Variant of Frontotemporal Dementia: A PRISMA-Compliant Systematic Review
por: Chatzidimitriou, Electra, et al.
Publicado: (2023)

Stress, Anxiety, and Depression Levels among University Students: Three Years from the Beginning of the Pandemic
por: Kavvadas, Dimitrios, et al.
Publicado: (2023)

Resilience in Mild Cognitive Impairment (MCI): Examining the Level and the Associations of Resilience with Subjective Wellbeing and Negative Affect in Early and Late-Stage MCI
por: Tsormpatzoudi, Styliani Olympia, et al.
Publicado: (2023)

Stress, Anxiety and Depression Prevalence among Greek University Students during COVID-19 Pandemic: A Two-Year Survey
por: Kavvadas, Dimitrios, et al.
Publicado: (2022)

Metacognitive Strategy Training Improves Decision-Making Abilities in Amnestic Mild Cognitive Impairment
por: Pikouli, Foteini Aikaterini, et al.
Publicado: (2023)

Episodic Memory in Amnestic Mild Cognitive Impairment (aMCI) and Alzheimer’s Disease Dementia (ADD): Using the “Doors and People” Tool to Differentiate between Early aMCI—Late aMCI—Mild ADD Diagnostic Groups
por: Chatzikostopoulos, Athanasios, et al.
Publicado: (2022)

Usefulness of event-related potentials in the assessment of mild cognitive impairment
por: Papaliagkas, Vasileios, et al.
Publicado: (2008)

Metacognitive Differences in Amnestic Mild Cognitive Impairment and Healthy Cognition: A Cross-Sectional Study Employing Online Measures
por: Bampa, Grigoria, et al.
Publicado: (2023)

CSF tau and β-amyloid as biomarkers for mild cognitive impairment
por: Hampel, Harald, et al.
Publicado: (2004)

Depressive symptoms and CSF Alzheimer's disease biomarkers in relation to clinical symptom onset of mild cognitive impairment
por: Chan, Carol K., et al.
Publicado: (2020)

Testosterone-induced hypertrophy, fibrosis and apoptosis of cardiac cells – an ultrastructural and immunohistochemical study
por: Papamitsou, Theodora, et al.
Publicado: (2011)

Correlates of Subjective and Mild Cognitive Impairment: Depressive Symptoms and CSF Biomarkers
por: Grambaite, Ramune, et al.
Publicado: (2013)

Association Analysis of Peripheral and CSF Biomarkers in Late Mild Cognitive Impairment
por: Zhang, Tao, et al.
Publicado: (2020)

Male patient with mild cognitive impairment and extremely high P300 and Slow-wave latencies: a case report
por: Papaliagkas, Vasileios T, et al.
Publicado: (2009)

Evaluation of Synaptic and Axonal Dysfunction Biomarkers in Alzheimer’s Disease and Mild Cognitive Impairment Based on CSF and Bioinformatic Analysis
por: Dulewicz, Maciej, et al.
Publicado: (2022)

Toxic Environmental Factors and their Association with the Development of Dementia: a Mini Review on Heavy Metals and Ambient Particulate Matter
por: Antoniadou, Fevronia, et al.
Publicado: (2020)

Association of microRNA Polymorphisms with Toxicities Induced by Methotrexate in Children with Acute Lymphoblastic Leukemia
por: Karpa, Vasiliki, et al.
Publicado: (2023)

Histologic evaluation of femoral nerve demyelinating and axonal neuropathy in Wistar rats due to alendronate intake: a randomised study
por: Theodora, Papamitsou, et al.
Publicado: (2020)

Selection of subjects for clinical trials in Alzheimer’s disease and mild cognitive impairment with machine learning analysis of MRI and CSF biomarkers
por: Escudero, Javier, et al.
Publicado: (2011)

Visit-to-Visit Blood Pressure Variability and CSF Alzheimer Disease Biomarkers in Cognitively Unimpaired and Mildly Impaired Older Adults
por: Sible, Isabel J., et al.
Publicado: (2022)

Comparison of Brief Cognitive Tests and CSF Biomarkers in Predicting Alzheimer’s Disease in Mild Cognitive Impairment: Six-Year Follow-Up Study
por: Palmqvist, Sebastian, et al.
Publicado: (2012)

The Effects of CSF Neurogranin and APOE ε4 on Cognition and Neuropathology in Mild Cognitive Impairment and Alzheimer’s Disease
por: Fan, Yulan, et al.
Publicado: (2021)

Association of CSF GAP-43 and APOE ε4 with Cognition in Mild Cognitive Impairment and Alzheimer’s Disease
por: Zhu, Yueli, et al.
Publicado: (2022)

R4Alz-Revised: A Tool Able to Strongly Discriminate ‘Subjective Cognitive Decline’ from Healthy Cognition and ‘Minor Neurocognitive Disorder’
por: Poptsi, Eleni, et al.
Publicado: (2023)

Plasma biomarkers for diagnosis of Alzheimer's disease and prediction of cognitive decline in individuals with mild cognitive impairment
por: Kivisäkk, Pia, et al.
Publicado: (2023)

CSF Biomarkers for Alzheimer's Disease Diagnosis
por: Anoop, A., et al.
Publicado: (2010)

Differential White Matter Connectivity in Early Mild Cognitive Impairment According to CSF Biomarkers
por: Lim, Jae-Sung, et al.
Publicado: (2014)

Intranasal Insulin Reduces White Matter Hyperintensity Progression in Association with Improvements in Cognition and CSF Biomarker Profiles in Mild Cognitive Impairment and Alzheimer’s Disease
por: Kellar, D., et al.
Publicado: (2021)

Cerebrospinal Fluid Biomarkers for the Diagnosis of Prodromal Alzheimer's Disease in Amnestic Mild Cognitive Impairment
por: Park, Jung Eun, et al.
Publicado: (2019)

Diagnosis and Staging of Pediatric Non-Alcoholic Fatty Liver Disease: Is Classical Ultrasound the Answer?
por: Papachristodoulou, Angeliki, et al.
Publicado: (2021)

Inefficient understanding of non-factive mental verbs with social aspect in adults: comparison to cognitive factive verb processing
por: Nazlidou, Elena-Ioanna, et al.
Publicado: (2018)

Identification of Altered Metabolic Pathways in Plasma and CSF in Mild Cognitive Impairment and Alzheimer’s Disease Using Metabolomics
por: Trushina, Eugenia, et al.
Publicado: (2013)

Blood and CSF chemokines in Alzheimer’s disease and mild cognitive impairment: a systematic review and meta-analysis
por: Zhou, Futao, et al.
Publicado: (2023)

Sequential Membrane Filtration to Recover Polyphenols and Organic Acids from Red Wine Lees: The Antioxidant Properties of the Spray-Dried Concentrate
por: Filippou, Polychronis, et al.
Publicado: (2022)

Optimization of Sensory Properties of Cold Brew Coffee Produced by Reduced Pressure Cycles and Its Physicochemical Characteristics
por: Kyroglou, Smaro, et al.
Publicado: (2022)

Neural biomarker diagnosis and prediction to mild cognitive impairment and Alzheimer’s disease using EEG technology
por: Jiao, Bin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_r633u5sln80q9246a91t8b7h64